Cirsium japonicum flavones enhance adipocyte differentiation and glucose uptake in 3T3-L1 cells

Biological and Pharmaceutical Bulletin

Volumn 35, Issue 6, 2012, Pages 855-860

  Liao, Zhiyong ^a   Wu, Zhihua ^b   Wu, Mingjiang ^a  

^a WENZHOU UNIVERSITY   (China)

^b NANCHANG UNIVERSITY   (China)

Author keywords

Adipocyte differentiation; Adiponectin; Cirsium japonicum; Flavone; Glucose transporter 4; Peroxisome proliferator activated receptor

Indexed keywords

2 CHLORO 5 NITROBENZANILIDE; 5,7 DIHYDROXY 6,4 DIMETHOXYFLAVONE; ADIPONECTIN; DYE; FLAVONE DERIVATIVE; GLUCOSE; GLUCOSE TRANSPORTER 4; INSULIN; MESSENGER RNA; OIL RED O; PECTOLINARIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; ROSIGLITAZONE; UNCLASSIFIED DRUG; WORTMANNIN;

ADIPOCYTE; ADIPOGENESIS; ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL MATURATION; CELL MEMBRANE; CELL STIMULATION; CELL STRAIN 3T3; CIRSIUM; CIRSIUM JAPONICUM; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIABETES MELLITUS; DRUG MECHANISM; DRUG STRUCTURE; GENE TARGETING; GLUCOSE TRANSPORT; INSULIN METABOLISM; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN TRANSPORT; RECEPTOR UPREGULATION; REPORTER GENE; SIGNAL TRANSDUCTION;

EID: 84861851154     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.35.855     Document Type: Article

References (37)

1. Travers ME, McCarthy MI. Type 2 diabetes and obesity: genomics and the clinic. Hum. Genet., 130, 41-58 (2011).
2. Jafar-Mohammadi B, McCarthy MI. Genetics of type 2 diabetes mellitus and obesity-a review. Ann. Med., 40, 2-10 (2008).
3. Siersbaek R, Nielsen R, Mandrup S. PPARgamma in adipocyte differentiation and metabolism-novel insights from genome-wide studies. FEBS Lett., 584, 3242-3249 (2010).
4. Kamon J, Yamauchi T, Kadowaki T. PPAR family (PPAR alpha, PPAR delta, PPAR gamma). Nippon Rinsho, 60 (Suppl. 7), 593-600 (2002).
5. Brun RP, Spiegelman BM. PPAR gamma and the molecular control of adipogenesis. J. Endocrinol., 155, 217-218 (1997).
6. Lehrke M, Lazar MA. The many faces of PPARgamma. Cell, 123, 993-999 (2005).
7. Rabe K, Lehrke M, Parhofer KG, Broedl UC. Adipokines and insulin resistance. Mol. Med., 14, 741-751 (2008).
8. Leff T, Mathews ST, Camp HS. Review: peroxisome proliferator-activated receptor-gamma and its role in the development and treatment of diabetes. Exp. Diabesity Res., 5, 99-109 (2004).
9. Barroso I, Gurnell M, Crowley VE, Agostini M, Schwabe JW, Soos MA, Maslen GL, Williams TD, Lewis H, Schafer AJ, Chatterjee VK, O'Rahilly S. Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus and hypertension. Nature, 402, 880-883 (1999).
10. Doney AS, Fischer B, Leese G, Morris AD, Palmer CN. Cardiovascular risk in type 2 diabetes is associated with variation at the PPARG locus: a Go-DARTS study. Arterioscler. Thromb. Vasc. Biol., 24, 2403-2407 (2004).
11. Monajemi H, Zhang L, Li G, Jeninga EH, Cao H, Maas M, Brouwer CB, Kalkhoven E, Stroes E, Hegele RA, Leff T. Familial partial lipodystrophy phenotype resulting from a single-base mutation in deoxyribonucleic acid-binding domain of peroxisome proliferator-activated receptor-gamma. J. Clin. Endocrinol. Metab., 92, 1606-1612 (2007).
12. Semple RK, Chatterjee VK, O'Rahilly S. PPAR gamma and human metabolic disease. J. Clin. Invest., 116, 581-589 (2006).
13. Staels B, Fruchart JC. Therapeutic roles of peroxisome proliferator-activated receptor agonists. Diabetes, 54, 2460-2470 (2005).
14. Han KL, Jung MH, Sohn JH, Hwang JK. Ginsenoside 20Sprotopanaxatriol (PPT) activates peroxisome proliferator-activated receptor gamma (PPARgamma) in 3T3-L1 adipocytes. Biol. Pharm. Bull., 29, 110-113 (2006).
15. Choi SS, Cha BY, Iida K, Lee YS, Yonezawa T, Teruya T, Nagai K, Woo JT. Artepillin C, as a PPARγ ligand, enhances adipocyte differentiation and glucose uptake in 3T3-L1 cells. Biochem. Pharmacol., 81, 925-933 (2011).
16. Yang Y, Shang W, Zhou L, Jiang B, Jin H, Chen M. Emodin with PPARgamma ligand-binding activity promotes adipocyte differentiation and increases glucose uptake in 3T3-Ll cells. Biochem. Biophys. Res. Commun., 353, 225-230 (2007).
17. Shin DW, Kim SN, Lee SM, Lee W, Song MJ, Park SM, Lee TR, Baik JH, Kim HK, Hong JH, Noh M. (-)-Catechin promotes adipocyte differentiation in human bone marrow mesenchymal stem cells through PPAR gamma transactivation. Biochem. Pharmacol., 77, 125-133 (2009).
18. Choi SS, Cha BY, Lee YS, Yonezawa T, Teruya T, Nagai K, Woo JT. Magnolol enhances adipocyte differentiation and glucose uptake in 3T3-L1 cells. Life Sci., 84, 908-914 (2009).
19. Liu SJ, Luo X, Li DX, Zhang J, Qiu DL, Liu W, She L, Yang ZR. Tumor inhibition and improved immunity in mice treated with flavone from Cirsium japonicum DC. Int. Immunopharmacol., 6, 1387-1393 (2006).
20. Jeong M, Jung HA, Choi JS. Comparative antioxidant activity and HPLC profiles of some selected Korean thistles. Arch. Pharm. Res., 31, 28-33 (2008).
21. Yin J, Heo SI, Wang MH. Antioxidant and antidiabetic activities of extracts from Cirsium japonicum roots. Nutr. Res. Pract., 2, 247-251 (2008).
22. Liao ZY, Chen XL, Wu MJ. Antidiabetic effect of flavones from Cirsium japonicum DC in diabetic rats. Arch. Pharm. Res., 33, 353-362 (2010).
23. Spiegelman BM. PPAR-gamma: adipogenic regulator and thiazolidinedione receptor. Diabetes, 47, 507-514 (1998).
24. Tafuri SR. Troglitazone enhances differentiation, basal glucose uptake, and Glut1 protein levels in 3T3-L1 adipocytes. Endocrinology, 137, 4706-4712 (1996).
25. Khan AH, Pessin JE. Insulin regulation of glucose uptake: a complex interplay of intracellular signalling pathways. Diabetologia, 45, 1475-1483 (2002).
26. Guerre-Millo M. Adipose tissue and adipokines: for better or worse. Diabetes Metab., 30, 13-19 (2004).
27. Yamauchi T, Kamon J, Waki H, Murakami K, Motojima K, Komeda K, Ide T, Kubota N, Terauchi Y, Tobe K, Miki H, Tsuchida A, Akanuma Y, Nagai R, Kimura S, Kadowaki T. The mechanisms by which both heterozygous peroxisome proliferator-activated receptor gamma (PPARgamma) deficiency and PPARgamma agonist improve insulin resistance. J. Biol. Chem., 276, 41245-41254 (2001).
28. Sheng X, Zhang Y, Gong Z, Huang C, Zang YQ. Improved insulin resistance and lipid metabolism by cinnamon extract through activation of peroxisome proliferator-activated receptors. PPAR Res., 2008, 581348 (2008).
29. de Souza CJ, Eckhardt M, Gagen K, Dong M, Chen W, Laurent D, Burkey BF. Effects of pioglitazone on adipose tissue remodeling within the setting of obesity and insulin resistance. Diabetes, 50, 1863-1871 (2001).
30. Yokoi H, Mizukami H, Nagatsu A, Ohno T, Tanabe H, Inoue M. Peroxisome proliferator-activated receptor gamma ligands isolated from adlay seed (Coix lacryma-jobi L. var. ma-yuen STAPF.). Biol. Pharm. Bull., 32, 735-740 (2009).
31. Zhang WY, Lee JJ, Kim IS, Kim Y, Park JS, Myung CS. 7-O- methylaromadendrin stimulates glucose uptake and improves insulin resistance in vitro. Biol. Pharm. Bull., 33, 1494-1499 (2010).
32. Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, Hotta K, Shimomura I, Nakamura T, Miyaoka K, Kuriyama H, Nishida M, Yamashita S, Okubo K, Matsubara K, Muraguchi M, Ohmoto Y, Funahashi T, Matsuzawa Y. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem. Biophys. Res. Commun., 257, 79-83 (1999).
33. Li S, Shin HJ, Ding EL, van Dam RM. Adiponectin levels and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA, 302, 179-188 (2009).
34. Fruebis J, Tsao TS, Javorschi S, Ebbets-Reed D, Erickson MR, Yen FT, Bihain BE, Lodish HF. Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc. Natl. Acad. Sci. U.S.A., 98, 2005-2010 (2001).
35. Carvalho E, Kotani K, Peroni OD, Kahn BB. Adipose-specific overexpression of GLUT4 reverses insulin resistance and diabetes in mice lacking GLUT4 selectively in muscle. Am. J. Physiol. Endocrinol. Metab., 289, E551-E561 (2005).
36. Ribon V, Johnson JH, Camp HS, Saltiel AR. Thiazolidinediones and insulin resistance: peroxisome proliferatoractivated receptor gamma activation stimulates expression of the CAP gene. Proc. Natl. Acad. Sci. U.S.A., 95, 14751-14756 (1998).
37. Watson RT, Kanzaki M, Pessin JE. Regulated membrane trafficking of the insulin-responsive glucose transporter 4 in adipocytes. Endocr. Rev., 25, 177-204 (2004).